A recent study published in the Journal of Allergy and Clinical Immunology (JACI), titled “Loss of symbiotic gut bacteria in children at diagnosis of food protein induced enterocolitis syndrome,” has identified notable differences in the gut microbiota of children diagnosed with Food Protein-Induced Enterocolitis Syndrome (FPIES). FPIES is a rare and often severe non-IgE-mediated food allergy characterized by delayed gastrointestinal symptoms such as profuse vomiting and lethargy. Researchers from Umeå University found that children with this condition were observed to have a “clearly altered gut microbiota” compared to their healthy peers, offering new insight into a disease where the underlying biological mechanisms have long remained unclear.
The investigation involved a detailed analysis of stool samples from 56 children newly diagnosed with FPIES, comparing them against a control group of 43 age-matched children without allergies. The study found that while age is the most dominant factor in shaping the gut microbiota during the first year of life, FPIES was associated with notable differences in gut composition. As Associate Professor Kotryna Simonyte Sjödin noted, “Our results reveal clear differences in the gut bacterial composition of children with FPIES, an area where knowledge has so far been limited.”
A primary finding of the research was a reduction in beneficial, symbiotic bacteria in the guts of affected infants. Specifically, children with FPIES exhibited lower levels of Bifidobacterium and Verrucomicrobiota, taxa typically associated with a healthy, balanced immune system. The researchers suggest that this reduction at the time of diagnosis may indicate that the microbial environment plays a role in the condition, though further research is needed to understand the direction of this relationship.
Conversely, the study identified higher abundances of certain bacteria that may contribute to a more inflammatory environment. Increased levels of Bacteroides, Haemophilus, and Veillonella were observed in children with FPIES. The research also found that common trigger foods—such as cow’s milk or grains—were associated with additional variations in microbiota composition, suggesting that gut bacterial patterns may differ depending on the specific trigger involved.
The clinical implications of these findings are significant, particularly given the challenges of diagnosing rare allergic conditions. “FPIES is a clinically challenging diagnosis, and today we lack reliable biomarkers,” explained Anna Winberg, a senior consultant and associate professor involved in the study. Identifying consistent microbial patterns may help inform future efforts to develop stool-based biomarkers that could complement current diagnostic approaches.
The study also aligns with broader research supporting the “biodiversity hypothesis,” which suggests that early-life microbial exposure plays a key role in immune system development. While the altered microbiota observed in children with FPIES is evident at diagnosis, its role in disease development remains unclear. Dr Christina West emphasized the long-term potential of this work, noting that such findings may contribute to more individualized approaches to diagnosis, prevention, and treatment over time.
Ultimately, this research highlights the gut as an important area of focus in understanding pediatric food allergies. By identifying atypical microbiota patterns in children with FPIES, scientists are beginning to build a clearer picture of the condition. These insights may eventually inform new strategies—including targeted probiotics or dietary approaches—aimed at restoring microbial balance, though such applications remain under investigation.
